Item Type | Name |
Academic Article
|
Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.
|
Academic Article
|
Identification of patients with arthritis and arthritis-related functional limitation using administrative data.
|
Academic Article
|
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis.
|
Academic Article
|
Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.
|
Academic Article
|
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry.
|
Academic Article
|
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
|
Academic Article
|
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry.
|
Academic Article
|
Malignancy validation in a United States registry of rheumatoid arthritis patients.
|
Academic Article
|
Time trends in medication use and expenditures in older patients with rheumatoid arthritis.
|
Academic Article
|
The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review.
|
Academic Article
|
Cost-related medication nonadherence in older patients with rheumatoid arthritis.
|
Academic Article
|
Association between anti-TNF-a therapy and interstitial lung disease.
|
Academic Article
|
Validation of a surveillance case definition for arthritis.
|
Academic Article
|
Validity of gout diagnoses in administrative data.
|
Academic Article
|
Adherence with urate-lowering therapies for the treatment of gout.
|
Academic Article
|
Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.
|
Academic Article
|
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.
|
Academic Article
|
Cardiovascular risk in rheumatoid arthritis: comparing TNF-a blockade with nonbiologic DMARDs.
|
Concept
|
Arthritis, Juvenile
|
Concept
|
Arthritis, Rheumatoid
|
Concept
|
Arthritis, Psoriatic
|
Concept
|
Arthritis
|
Academic Article
|
Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist.
|
Academic Article
|
Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.
|
Academic Article
|
Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African-American rheumatoid arthritis patients.
|
Academic Article
|
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs.
|
Academic Article
|
Dr. Harrold, et al reply.
|
Academic Article
|
Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.
|
Academic Article
|
A description of patient- and rheumatologist-reported depression symptoms in an American rheumatoid arthritis registry population.
|
Academic Article
|
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.
|
Academic Article
|
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.
|
Academic Article
|
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.
|
Academic Article
|
Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.
|
Academic Article
|
Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity.
|
Academic Article
|
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.
|
Academic Article
|
Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.
|
Academic Article
|
Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009.
|
Academic Article
|
Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability.
|
Academic Article
|
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.
|
Academic Article
|
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
|
Academic Article
|
Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry.
|
Academic Article
|
A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.
|
Academic Article
|
Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial.
|
Academic Article
|
Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients.
|
Academic Article
|
Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry.
|
Academic Article
|
Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.
|
Academic Article
|
The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.
|
Academic Article
|
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
|
Academic Article
|
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.
|
Academic Article
|
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.
|
Academic Article
|
Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial.
|
Academic Article
|
Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis.
|
Academic Article
|
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-a Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study.
|
Academic Article
|
Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial.
|
Academic Article
|
Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry.
|
Academic Article
|
One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry.
|
Academic Article
|
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
|
Academic Article
|
Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis.
|
Academic Article
|
Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity.
|
Academic Article
|
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis.
|
Academic Article
|
Adverse Events and Resource Use Before and After Treat-to-Target in Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.
|
Academic Article
|
Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry.
|
Academic Article
|
Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.
|
Academic Article
|
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.
|
Academic Article
|
Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.
|
Academic Article
|
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
|
Academic Article
|
Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry.
|
Academic Article
|
Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.
|
Academic Article
|
Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry.
|
Academic Article
|
Association among anti-citrullinated protein antibody status, erosive disease and healthcare resource utilization in patients with rheumatoid arthritis.
|
Academic Article
|
Assessing disease severity in bio-na?ve patients with RA on treatment with csDMARDs: insights from the Corrona Registry.
|
Academic Article
|
Prevalence of Sj?gren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry.
|
Academic Article
|
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
|
Academic Article
|
2020 American College of Rheumatology Guideline for the Management of Gout.
|
Academic Article
|
2020 American College of Rheumatology Guideline for the Management of Gout.
|
Academic Article
|
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sj?gren's syndrome enrolled in a large observational US registry.
|
Academic Article
|
Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results.
|
Academic Article
|
The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
|
Academic Article
|
Evaluation of an Intervention to Support Patient-Rheumatologist Conversations About Escalating Treatment in Patients with Rheumatoid Arthritis: A Proof-of-Principle Study.
|
Academic Article
|
Obesity and Response to Advanced Therapies in Rheumatoid Arthritis.
|
Academic Article
|
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular Risk.
|
Academic Article
|
Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat-to-Target Rates.
|
Academic Article
|
Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry.
|
Academic Article
|
Reply.
|
Academic Article
|
Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses.
|
Academic Article
|
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP.
|
Academic Article
|
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis.
|
Academic Article
|
Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic review.
|
Academic Article
|
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.
|
Academic Article
|
Understanding Heterogeneity in Patients' Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis.
|
Academic Article
|
Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry.
|
Academic Article
|
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive.
|
Academic Article
|
Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
|
Academic Article
|
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study.
|